Healthcare provider profile · identity verified

Stacey Lee Brown, MD

Allopathic & Osteopathic Physicians|Family Medicine · BISHOP, CA · NPI 1629004650

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Stacey Lee Brown, MD received $13.72 in general payments during 2025 across 1 reported records.

Medline Industries LP accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$13.72

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Medline Industries LP	Unresolved — no canonical attribution shown	$13.72	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$13.72	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	370	68
Atorvastatin Calcium	Atorvastatin Calcium	236	56
Metoprolol Succinate	Metoprolol Succinate	184	41
Losartan Potassium	Losartan Potassium	172	36
Amlodipine Besylate	Amlodipine Besylate	147	28
Omeprazole	Omeprazole	144	33
Prednisone	Prednisone	132	31
Pantoprazole Sodium	Pantoprazole Sodium	130	21
Tamsulosin Hcl	Tamsulosin Hcl	126	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	121	43
Alprazolam	Alprazolam	116	25
Gabapentin	Gabapentin	113	33
Lisinopril	Lisinopril	108	27
Duloxetine Hcl	Duloxetine Hcl	96	13
Rosuvastatin Calcium	Rosuvastatin Calcium	95	25
Metformin Hcl	Metformin Hcl	88	18
Pregabalin	Pregabalin	74	19
Simvastatin	Simvastatin	74	12
Tramadol Hcl	Tramadol Hcl	73	22
Hydrochlorothiazide	Hydrochlorothiazide	71	15
Albuterol Sulfate Hfa	Albuterol Sulfate	69	24
Montelukast Sodium	Montelukast Sodium	69	14
Eliquis	Apixaban	68	15
Lorazepam	Lorazepam	65	12
Clonazepam	Clonazepam	63	16
Zolpidem Tartrate	Zolpidem Tartrate	59	17
Oxycodone Hcl	Oxycodone Hcl	58	suppressed
Citalopram Hbr	Citalopram Hydrobromide	55	11
Potassium Chloride	Potassium Chloride	52	13
Ozempic	Semaglutide	49	suppressed
Furosemide	Furosemide	48	suppressed
Trazodone Hcl	Trazodone Hcl	48	12
Bupropion Xl	Bupropion Hcl	47	suppressed
Celecoxib	Celecoxib	46	11
Famotidine	Famotidine	44	11
Metoprolol Tartrate	Metoprolol Tartrate	44	suppressed
Allopurinol	Allopurinol	42	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	suppressed
Finasteride	Finasteride	41	suppressed
Trulicity	Dulaglutide	41	suppressed
Atenolol	Atenolol	39	suppressed
Metformin Hcl Er	Metformin Hcl	39	suppressed
Estradiol	Estradiol	38	suppressed
Dutasteride	Dutasteride	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Spironolactone	Spironolactone	37	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Azithromycin	Azithromycin	34	13
Torsemide	Torsemide	34	suppressed
Carvedilol	Carvedilol	33	suppressed
Sertraline Hcl	Sertraline Hcl	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	30	suppressed
Meloxicam	Meloxicam	29	suppressed
Topiramate	Topiramate	29	suppressed
Diazepam	Diazepam	28	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Valacyclovir	Valacyclovir Hcl	26	11
Buspirone Hcl	Buspirone Hcl	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Cephalexin	Cephalexin	23	12
Creon	Lipase/Protease/Amylase	23	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	23	suppressed
Morphine Sulfate Er	Morphine Sulfate	23	suppressed
Fluconazole	Fluconazole	22	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Amoxicillin	Amoxicillin	21	suppressed
Armour Thyroid	Thyroid,pork	21	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Oxycontin	Oxycodone Hcl	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Testosterone	Testosterone	20	suppressed
Verapamil Sr	Verapamil Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Febuxostat	Febuxostat	19	suppressed
Ketoconazole	Ketoconazole	19	15
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Methimazole	Methimazole	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Buprenorphine	Buprenorphine	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Clonidine	Clonidine	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Valsartan	Valsartan	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Verapamil Er	Verapamil Hcl	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Colchicine	Colchicine	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Ramipril	Ramipril	16	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Progesterone	Progesterone, Micronized	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Belsomra	Suvorexant	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Mesalamine Er	Mesalamine	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Humira Pen	Adalimumab	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Primidone	Primidone	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Repatha Syringe	Evolocumab	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Apidra	Insulin Glulisine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Entecavir	Entecavir	11	suppressed
Hysingla Er	Hydrocodone Bitartrate	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$13.72 · 1 records	Medline Industries LP	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error